Summit Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Summit Financial's ABBV Position: Q2 2026 in Review
Summit Financial increased its AbbVie (ABBV) stake by 4.6% in Q2 2026, buying an estimated $878K and bringing the position to 93,109 shares worth $23.4M. The position accounts for 0.26% of the portfolio, ranked #77.
Summit Financial first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Summit Financial held 93,109 shares of AbbVie worth $23.4M as of Q2 2026.
- Summit Financial bought 4,080 AbbVie shares in Q2 2026, an estimated $878K.
- AbbVie made up 0.26% of Summit Financial's portfolio in Q2 2026, its #77 holding.
- Summit Financial first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.